Helus Pharma Inc. Common Stock
HELP
99 hedge funds and large institutions have $198M invested in Helus Pharma Inc. Common Stock in 2026 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 9 closing their positions.
291% more call options, than puts
Call options by funds: $8.27M | Put options by funds: $2.11M
211% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 9
107% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 14
71% more capital invested
Capital invested by funds: $116M → $198M (+$81.8M)
22% more funds holding
Funds holding: 81 → 99 (+18)
11.18% more ownership
Funds ownership: 46.7% → 57.87% (+11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11.8M |
| 2 |
SCM
Sio Capital Management
New York
|
+$6.5M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
+$3.75M |
| 4 |
DA
DCF Advisers
Greenwich,
Connecticut
|
+$3.72M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$6.77M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$6.3M |
| 3 |
Morgan Stanley
New York
|
-$2.82M |
| 4 |
O
OrbiMed
New York
|
-$2.81M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.28M |
HELP Hedge Fund Activity: Q2 2026 in Review
99 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Helus Pharma Inc. Common Stock (HELP) for Q2 2026, worth a combined $198M — up 71% from $116M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new HELP positions and 9 closed out — a net gain of 19 holders — while 29 added to existing stakes and 14 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $11.8M. The largest seller was Eventide Asset Management, exiting entirely with an estimated $6.77M sold.
- 99 institutional investors held Helus Pharma Inc. Common Stock (HELP) as of Q2 2026, up from 81 in Q1 2026.
- Funds reported $198M of Helus Pharma Inc. Common Stock stock for Q2 2026, up 71% quarter-over-quarter.
- 28 funds opened new Helus Pharma Inc. Common Stock positions in Q2 2026 and 9 closed out, a net change of +19 holders.
- The largest Helus Pharma Inc. Common Stock buyer in Q2 2026 was Adage Capital Partners, an estimated $11.8M added.
- The largest Helus Pharma Inc. Common Stock seller in Q2 2026 was Eventide Asset Management, an estimated $6.77M sold.
Based on aggregated 13F filings for Q2 2026.